Enhancing nonmass lesions in the breast: Evaluation with proton ( 1H) MR spectroscopy

Radiology

Volumn 245, Issue 1, 2007, Pages 80-87

  Bartella, Lia ^a   Thakur, Sunitha B ^a   Morris, Elizabeth A ^a   Dershaw, D David ^a   Huang, Wei ^a   Chough, Eugenia ^a   Cruz, Maria C ^a   Liberman, Laura ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE;

ADULT; ARTICLE; BENIGN TUMOR; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; STANDARD;

ADULT; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 34548685654     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2451061639     Document Type: Article

References (21)

1. Kuhl CK, Bieling HB, Gieseke J, et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement, and cyclical-phase dependency. Radiology 1997;203:137-144.
2. American College of Radiology. ACR BIRADS - Magnetic Resonance Imaging. In: ACR Breast Imaging Reporting & Data System, breast imaging atlas. Reston, Va: American College of Radiology, 2003.
3. Bartella L, Liberman L, Morris EA, Dershaw DD. Nonpalpable mammographically occult invasive breast cancers detected by MRI. AJR Am J Roentgenol 2000;186:865-870.
4. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006;238:42-53.
5. Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992;5:303-324.
6. Bartella L, Morris EA, Dershaw DD, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for hreast cancer diagnosis: preliminary study. Radiology 2006;239:686-692.
7. Bolan PJ, Meisamy S, Baker EH, et al. In vivo quantification of choline compounds in the breast wilh 1H MR spectroscopy. Magn Reson Med 2003;50:1134-1143.
8. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68:45-54.
9. Gribbestad IS, Singstad TE, Nilsen G, et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998;8:1191-1197.
10. Huang W, Fisher PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 2004;232:585-591.
11. Jacobs MA, Barker PB, Bottomley PA, Bhujwalla Z, Bluemke DA. Proton magnetic resonance spectroscopic imaging of human breast cancer: a preliminary study. J Magn Reson Imaging 2004;19:68-75.
12. Kvistad KA, Bakken IJ, Gribbestad IS, et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999;10:159-164.
13. Roebuck JR, Cecil KM, Schnall MD, Lenkinski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998;209:269-275.
14. Tse GM, Cheung HS, Pang LM, et al. Characterization of lesions of the breast with proton MR spectroscopy: comparison of carcinomas, benign lesions, and phyllodes tumors. AJR Am J Roentgenol 2003;181:1267-1272.
15. Yeung DK, Cheung HS, Tse GM. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy - initial results. Radiology 2001;220:40-46.
16. Jagannathan NR, Kumar M, Seenu V, et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001;84:1016-1022.
17. Liberman L, Bracero N, Morris E, Thornton C, Dershaw DD. MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience. AJR Am J Roentgenol 2005;185:183-193.
18. Morris EA, Liberman L, Dershaw DD, et al. Preoperative MR imaging-gnided needle localization of breast lesions. AJR Am J Roentgenol 2002;178:1211-1220.
19. Leisenring W, Alonzo T, Pepe MS. Comparisons of predictive values of binary medical diagnostic tests for paired designs. Biometrics 2000;56:345-351.
20. Yeung DK, Yang WT, Tse GM. Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. Radiology 2002;225:190-197.
21. LaTrenta LR, Menell JH, Morris EA, Abramson AF, Dershaw DD, Liberman L. Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US. Radiology 2003;227:856-861.